Drugs Approved for Myeloproliferative Disorders
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative disorders. The list includes generic and brand names. This page also lists common drug combinations used in myeloproliferative disorders. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in myeloproliferative disorders that are not listed here.
Adriamycin PFS (Doxorubicin Hydrochloride)
Adriamycin RDF (Doxorubicin Hydrochloride)
Cerubidine (Daunorubicin Hydrochloride)
Gleevec (Imatinib Mesylate)
Jakafi (Ruxolitinib Phosphate)
Rubidomycin (Daunorubicin Hydrochloride)
Tarabine PFS (Cytarabine)
Trisenox (Arsenic Trioxide)
Vincasar PFS (Vincristine Sulfate)
Drug Combinations Used in Myeloproliferative Disorders